Back to GetFilings.com



Table of Contents

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 

 
FORM 10-Q
 
Mark One
 
x
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2002
 
or
 
¨
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM                      TO                     
 

 
Commission File Number: 000-30681
 
DENDREON CORPORATION
(Exact name of registrant as specified in its charter)
 
DELAWARE
 
22-3203193
(State or other jurisdiction of incorporation or organization)
 
(IRS Employer Identification No.)
 
3005 FIRST AVENUE, SEATTLE, WASHINGTON 98121
(Address of principal executive offices, including zip code)
 
(206) 256-4545
(Registrant’s telephone number, including area code)
 

 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    x  Yes   ¨  No
 
The number of shares of the registrant’s common stock, $.001 par value, outstanding as of July 31, 2002 was 25,280,531.
 


Table of Contents
 
DENDREON CORPORATION
 
INDEX
 
                
PAGE NO.

PART I.
  
FINANCIAL INFORMATION
      
    
Item 1.
  
Financial Statements
      
              
2
              
3
              
4
              
5
    
Item 2.
       
6
    
Item 3.
       
18
PART II.
  
OTHER INFORMATION
      
    
Item 2.
       
19
    
Item 4.
       
19
    
Item 6.
       
19
    
20
    
21


Table of Contents
 
PART 1—FINANCIAL INFORMATION
 
ITEM 1.    FINANCIAL STATEMENTS
 
DENDREON CORPORATION
 
CONDENSED BALANCE SHEETS
(in thousands, except share and per share amounts)
 
    
June 30,
2002

    
December 31, 2001

 
    
(unaudited)
        
ASSETS
                 
Current assets:
                 
Cash and cash equivalents
  
$
26,217
 
  
$
13,912
 
Short-term investments
  
 
34,088
 
  
 
56,969
 
Accounts receivable
  
 
1,649
 
  
 
1,955
 
Other current assets
  
 
2,482
 
  
 
3,253
 
    


  


Total current assets
  
 
64,436
 
  
 
76,089
 
Property and equipment, net
  
 
3,944
 
  
 
3,858
 
Long-term investments
  
 
3,067
 
  
 
10,361
 
Deposits and other assets
  
 
766
 
  
 
774
 
    


  


Total Assets
  
$
72,213
 
  
$
91,082
 
    


  


LIABILITIES AND STOCKHOLDERS’ EQUITY
                 
Current liabilities:
                 
Accounts payable
  
$
247
 
  
$
932
 
Accrued liabilities
  
 
4,301
 
  
 
4,524
 
Accrued compensation
  
 
1,127
 
  
 
1,975
 
Deferred revenue
  
 
6,904
 
  
 
7,572
 
Current portion of long-term debt
  
 
—  
 
  
 
281
 
Current portion of capital lease obligations
  
 
985
 
  
 
1,120
 
    


  


Total current liabilities
  
 
13,564
 
  
 
16,404
 
Deferred revenue, less current portion
  
 
5,031
 
  
 
7,454
 
Capital lease obligations, less current portion
  
 
1,529
 
  
 
2,013
 
Commitments
  
 
—  
 
  
 
—  
 
Stockholders’ equity:
                 
Common stock, $0.001 par value; 80,000,000 shares authorized, 25,168,975 and 24,919,696 shares issued and outstanding at June 30, 2002 and December 31, 2001, respectively
  
 
25
 
  
 
25
 
Additional paid-in capital
  
 
156,904
 
  
 
156,481
 
Deferred stock-based compensation
  
 
(587
)
  
 
(987
)
Accumulated other comprehensive income
  
 
174
 
  
 
486
 
Accumulated deficit
  
 
(104,427
)
  
 
(90,794
)
    


  


Total stockholders’ equity
  
 
52,089
 
  
 
65,211
 
    


  


Total Liabilities and Stockholders’ Equity
  
$
72,213
 
  
$
91,082
 
    


  


2


Table of Contents
 
DENDREON CORPORATION
 
CONDENSED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
(Unaudited)
 
    
Three Months Ended
June 30,

    
Six Months Ended
June 30,

 
    
2002

    
2001

    
2002

    
2001

 
Revenue:
                                   
Collaborative and license revenue
  
$
3,114
 
  
$
2,982
 
  
$
6,142
 
  
$
6,048
 
Grant revenue
  
 
—  
 
  
 
89
 
  
 
—  
 
  
 
140
 
    


  


  


  


Total revenue
  
 
3,114
 
  
 
3,071
 
  
 
6,142
 
  
 
6,188
 
Operating expenses:
                                   
Research and development
  
 
7,421
 
  
 
7,161
 
  
 
15,797
 
  
 
12,421
 
General and administrative
  
 
2,127
 
  
 
1,891
 
  
 
4,444
 
  
 
3,530
 
Marketing
  
 
217
 
  
 
330
 
  
 
478
 
  
 
964
 
    


  


  


  


Total operating expenses
  
 
9,765
 
  
 
9,382
 
  
 
20,719
 
  
 
16,915
 
    


  


  


  


Loss from operations
  
 
(6,651
)
  
 
(6,311
)
  
 
(14,577
)
  
 
(10,727
)
Interest income, net:
                                   
Interest income
  
 
483
 
  
 
1,236
 
  
 
1,115
 
  
 
2,744
 
Interest expense
  
 
(82
)
  
 
(146
)
  
 
(171
)
  
 
(280
)
    


  


  


  


Interest income, net
  
 
401
 
  
 
1,090
 
  
 
944
 
  
 
2,464
 
    


  


  


  


Net loss
  
 
(6,250
)
  
 
(5,221
)
  
 
(13,633
)
  
 
(8,263
)
    


  


  


  


Basic and diluted net loss per share
  
$
(0.25
)
  
$
(0.21
)
  
$
(0.54
)
  
$
(0.34
)
    


  


  


  


Shares used in computation of basic and diluted net loss per share
  
 
25,111
 
  
 
24,723
 
  
 
25,047
 
  
 
24,654
 
    


  


  


  


3


Table of Contents
 
DENDREON CORPORATION
 
CONDENSED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
 
    
Six Months Ended
June 30,

 
    
2002

    
2001

 
OPERATING ACTIVITIES
                 
Net loss
  
$
(13,633
)
  
$
(8,263
)
Adjustments to reconcile net loss to net cash used in operating activities:
                 
Depreciation expense
  
 
859
 
  
 
505
 
Non-cash stock-based compensation expense
  
 
373
 
  
 
615
 
Non-cash consulting expense
  
 
—  
 
  
 
60
 
Non-cash interest expense
  
 
6
 
  
 
60
 
Changes in current assets and liabilities
                 
Accounts receivable
  
 
306
 
  
 
5,996
 
Other current assets
  
 
765
 
  
 
(1,000
)
Deferred revenue
  
 
(3,091
)
  
 
(4,666
)
Accounts payable
  
 
(685
)
  
 
(213
)
Accrued liabilities and compensation
  
 
(1,071
)
  
 
(493
)
    


  


Net cash used in operating activities
  
 
(16,171
)
  
 
(7,399
)
    


  


INVESTING ACTIVITIES
                 
Purchases of investments
  
 
(62,459
)
  
 
(54,837
)
Maturities of investments
  
 
92,330
 
  
 
30,669
 
Purchases of property and equipment
  
 
(945
)
  
 
(1,898
)
    


  


Net cash provided by (used in) investing activities
  
 
28,926
 
  
 
(26,066
)
    


  


FINANCING ACTIVITIES
                 
Payments on long-term debt
  
 
(281
)
  
 
(757
)
Proceeds from capital lease financing agreement
  
 
—  
 
  
 
960
 
Payments on capital lease obligations
  
 
(619
)
  
 
264
 
Proceeds from exercise of stock options
  
 
126
 
  
 
241
 
Issuance of common stock under the Employee Stock Purchase Plan
  
 
324
 
  
 
426
 
    


  


Net cash provided by (used in) financing activities
  
 
(450
)
  
 
606
 
    


  


NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
  
 
12,305</